Dr Andrew Maloney is speaking at this Royal Society of Chemistry (RSC) virtual event on how the CCDC are directing the development and application of predictive tools to enhance drug discovery and development.


Pharmaceutical development currently stands poised to benefit from the big data revolution, but not equipped with a platform to reap the potential rewards. Central to this opportunity is the Cambridge Structural Database (CSD), the world’s most comprehensive database of small molecule crystal structures.


Find out more or book your place on the RSC event page here.